EE200300373A - Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees - Google Patents

Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees

Info

Publication number: EE200300373A
Authority: EE; Estonia
Prior art keywords: synthesis; camptothecin analogs; preparation; compounds used; integral
Prior art date: 2001-02-21

Application number

EEP200300373A

Other languages

English (en)

Inventor

Ogawa Takanori

Nishiyama Hiroyuki

Uchida Miyuki

Sawada Seigo

Original Assignee

Kabushiki Kaisha Yakult Honsha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-21

Filing date

2002-02-21

Publication date

2003-10-15

2002-02-21 Application filed by Kabushiki Kaisha Yakult Honsha filed Critical Kabushiki Kaisha Yakult Honsha

2003-10-15 Publication of EE200300373A publication Critical patent/EE200300373A/et

2010-12-15 Publication of EE05361B1 publication Critical patent/EE05361B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
- C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C205/22—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having one nitro groups bound to the ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

EEP200300373A 2001-02-21 2002-02-21 Meetod kamptotetsiini analoogide snteesimiseks kasutatavate hendite valmistamiseks ning kamptotetsiini analoogide terviksntees EE05361B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001045430		2001-02-21
JP2001309322		2001-10-05
PCT/JP2002/001538 WO2002066416A1 (fr)	2001-02-21	2002-02-21	Procede de synthese de composes se rapportant a la camptothecine (cpt)

Publications (2)

Publication Number	Publication Date
EE200300373A true EE200300373A (et)	2003-10-15
EE05361B1 EE05361B1 (et)	2010-12-15

Family

ID=26609837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300373A EE05361B1 (et)	2001-02-21	2002-02-21	Meetod kamptotetsiini analoogide snteesimiseks kasutatavate hendite valmistamiseks ning kamptotetsiini analoogide terviksntees

Country Status (23)

Country	Link
US (2)	US7126000B2 (et)
EP (1)	EP1378505B1 (et)
JP (2)	JP4210119B2 (et)
KR (2)	KR100858972B1 (et)
CN (1)	CN100408550C (et)
AR (2)	AR035684A1 (et)
AU (1)	AU2002237527B2 (et)
BG (2)	BG108031A (et)
BR (1)	BR0207470A (et)
CA (2)	CA2437702C (et)
CZ (1)	CZ20032470A3 (et)
EE (1)	EE05361B1 (et)
HU (1)	HUP0302755A3 (et)
IL (2)	IL156949A0 (et)
MX (1)	MXPA03007528A (et)
NO (2)	NO328628B1 (et)
NZ (2)	NZ527615A (et)
PL (2)	PL218065B1 (et)
RO (2)	RO125158A2 (et)
RU (1)	RU2308447C2 (et)
SK (2)	SK288073B6 (et)
TW (1)	TWI245768B (et)
WO (1)	WO2002066416A1 (et)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ299329B6 (cs) *	2003-08-26	2008-06-18	Pliva-Lachema A.S.	Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) *	2003-12-16	2008-09-10	Pliva-Lachema A. S.	Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
US20080182990A1 (en) *	2004-08-09	2008-07-31	Shilpa Medicare Limited	Process for the Preparation of Irinotecan Hydrochloride Trihydrate
WO2006049447A1 (en) *	2004-11-05	2006-05-11	Samyang Corporation	Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents
ES2333462T3 (es) *	2005-02-07	2010-02-22	Fermion Oy	Procedimiento para la preparacion de 7-etil-10-hidroxi camptotecina.
JP5133703B2 (ja)	2005-02-08	2013-01-30	フェルミオンオサケユキチュア	［１，４’］ビピペリジニル−１’−カルボニルクロリドまたはその塩酸塩の製造方法
US7767813B2 (en)	2005-02-08	2010-08-03	Fermion Oy	Preparation method
US8112154B2 (en) *	2005-04-13	2012-02-07	The Cleveland Clinic Foundation	Systems and methods for neuromodulation using pre-recorded waveforms
TWI375678B (en) *	2005-06-09	2012-11-01	Yakult Honsha Kk	A method of preparation of a tricyclic ketone
WO2007015259A2 (en) *	2005-08-03	2007-02-08	Avra Laboratories Pvt. Ltd.	Method of synthesizing key intermediates for the production of camptothecin derivatives
EP1803725A1 (en) *	2005-12-13	2007-07-04	W.C. Heraeus GmbH	Methods for preparing irinotecan
US9220889B2 (en)	2008-02-11	2015-12-29	Intelect Medical, Inc.	Directional electrode devices with locating features
CN101824038B (zh) *	2009-03-06	2013-08-21	复旦大学	喜树碱及其类似物的制备方法
WO2011025865A1 (en)	2009-08-27	2011-03-03	The Cleveland Clinic Foundation	System and method to estimate region of tissue activation
JP5599094B2 (ja) *	2010-05-20	2014-10-01	国立大学法人千葉大学	ニトリル化合物の製造方法
JP5830090B2 (ja)	2010-06-14	2015-12-09	ボストンサイエンティフィックニューロモデュレイションコーポレイション	脊髄神経調節のためのプログラミングインターフェイス
AU2012294364A1 (en)	2011-08-09	2014-03-20	Boston Scientific Neuromodulation Corporation	Remote control for blind clinical trials of electrical stimulation
WO2014036075A1 (en)	2012-08-28	2014-03-06	Boston Scientific Neuromodulation Corporation	Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
WO2014070290A2 (en)	2012-11-01	2014-05-08	Boston Scientific Neuromodulation Corporation	Systems and methods for voa model generation and use
US8722886B1 (en) *	2012-11-13	2014-05-13	Bionumerik Pharmaceuticals, Inc.	Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin
US9959388B2 (en)	2014-07-24	2018-05-01	Boston Scientific Neuromodulation Corporation	Systems, devices, and methods for providing electrical stimulation therapy feedback
US10265528B2 (en)	2014-07-30	2019-04-23	Boston Scientific Neuromodulation Corporation	Systems and methods for electrical stimulation-related patient population volume analysis and use
US10272247B2 (en)	2014-07-30	2019-04-30	Boston Scientific Neuromodulation Corporation	Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming
WO2016057544A1 (en)	2014-10-07	2016-04-14	Boston Scientific Neuromodulation Corporation	Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
WO2016064900A1 (en) *	2014-10-22	2016-04-28	Arno Therapeutics, Inc.	Methods and systems for camptothecin analog synthesis
US9956419B2 (en)	2015-05-26	2018-05-01	Boston Scientific Neuromodulation Corporation	Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
US10780283B2 (en)	2015-05-26	2020-09-22	Boston Scientific Neuromodulation Corporation	Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
ES2940303T3 (es)	2015-06-29	2023-05-05	Boston Scient Neuromodulation Corp	Sistemas de selección de parámetros de estimulación por uso de dianas y direccionamiento
US20160375248A1 (en)	2015-06-29	2016-12-29	Boston Scientific Neuromodulation Corporation	Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects
EP3359252B1 (en)	2015-10-09	2020-09-09	Boston Scientific Neuromodulation Corporation	System and methods for clinical effects mapping for directional stimulations leads
US10716942B2 (en)	2016-04-25	2020-07-21	Boston Scientific Neuromodulation Corporation	System and methods for directional steering of electrical stimulation
EP3458152B1 (en)	2016-06-24	2021-04-21	Boston Scientific Neuromodulation Corporation	Systems and methods for visual analytics of clinical effects
WO2018044881A1 (en)	2016-09-02	2018-03-08	Boston Scientific Neuromodulation Corporation	Systems and methods for visualizing and directing stimulation of neural elements
US10780282B2 (en)	2016-09-20	2020-09-22	Boston Scientific Neuromodulation Corporation	Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters
CN109803719B (zh)	2016-10-14	2023-05-26	波士顿科学神经调制公司	用于闭环确定电模拟系统的刺激参数设置的系统和方法
JP6834005B2 (ja)	2017-01-03	2021-02-24	ボストンサイエンティフィックニューロモデュレイションコーポレイション	Ｍｒｉ適合刺激パラメータを選択するためのシステム及び方法
ES2821752T3 (es)	2017-01-10	2021-04-27	Boston Scient Neuromodulation Corp	Sistemas y procedimientos para crear programas de estimulación en base a áreas o volúmenes definidos por el usuario
US10625082B2 (en)	2017-03-15	2020-04-21	Boston Scientific Neuromodulation Corporation	Visualization of deep brain stimulation efficacy
US11357986B2 (en)	2017-04-03	2022-06-14	Boston Scientific Neuromodulation Corporation	Systems and methods for estimating a volume of activation using a compressed database of threshold values
US10716505B2 (en)	2017-07-14	2020-07-21	Boston Scientific Neuromodulation Corporation	Systems and methods for estimating clinical effects of electrical stimulation
US10960214B2 (en)	2017-08-15	2021-03-30	Boston Scientific Neuromodulation Corporation	Systems and methods for controlling electrical stimulation using multiple stimulation fields
WO2019210214A1 (en)	2018-04-27	2019-10-31	Boston Scientific Neuromodulation Corporation	Systems for visualizing and programming electrical stimulation
EP3784331B1 (en)	2018-04-27	2023-01-18	Boston Scientific Neuromodulation Corporation	Multi-mode electrical stimulation systems and methods of making and using
US11434196B2 (en) *	2019-01-15	2022-09-06	Laurus Labs Limited	Process for preparation of 2-Amino-5-hydroxy propiophenone
EP4291294A1 (en)	2021-04-27	2023-12-20	Boston Scientific Neuromodulation Corporation	Systems and methods for automated programming of electrical stimulation
EP4313269A1 (en)	2021-06-15	2024-02-07	Boston Scientific Neuromodulation Corporation	Methods and systems for estimating neural activation by stimulation using a stimulation system
EP4415809A2 (en)	2021-12-10	2024-08-21	Boston Scientific Neuromodulation Corporation	Systems and methods for generating and using response maps for electrical stimulation
CN118108705A (zh) *	2024-01-29	2024-05-31	浙江工业大学	一种富马酸沃诺拉赞的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2061678C1 (ru) *	1992-05-14	1996-06-10	Валерий Павлович Севодин	Способ получения 2-амино-5-нитробензофенона
US5391745A (en)	1992-07-23	1995-02-21	Sloan-Kettering Institute For Cancer Research	Methods of preparation of camptothecin analogs
JPH07101956A (ja) *	1993-10-05	1995-04-18	Tanabe Seiyaku Co Ltd	ヒドロキシカンプトテシン化合物の製法
KR960029336A (ko) *	1995-01-09	1996-08-17	김충환	캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
JPH08225482A (ja) *	1995-02-22	1996-09-03	Dai Ichi Seiyaku Co Ltd	テトラロン関連化合物及びその製法
IL117684A (en) *	1995-04-07	2002-02-10	Pharmacia & Upjohn Inc	Intermediates and Process for Production of History of Kempotocin (CPT-11) and Related Compounds
SG50747A1 (en) *	1995-08-02	1998-07-20	Tanabe Seiyaku Co	Comptothecin derivatives
EP0876373B1 (en)	1995-11-02	2005-08-10	OSI Pharmaceuticals, Inc.	Method for preparing camptothecin derivatives
SG104284A1 (en) *	1996-10-30	2004-06-21	Tanabe Seiyaku Co	S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof

2002
- 2002-02-20 TW TW091102967A patent/TWI245768B/zh not_active IP Right Cessation
- 2002-02-20 AR ARP020100579A patent/AR035684A1/es active IP Right Grant
- 2002-02-21 EP EP02703874.4A patent/EP1378505B1/en not_active Expired - Lifetime
- 2002-02-21 PL PL363440A patent/PL218065B1/pl unknown
- 2002-02-21 RO ROA200900165A patent/RO125158A2/ro unknown
- 2002-02-21 SK SK1147-2003A patent/SK288073B6/sk not_active IP Right Cessation
- 2002-02-21 US US10/467,987 patent/US7126000B2/en not_active Expired - Lifetime
- 2002-02-21 JP JP2002565934A patent/JP4210119B2/ja not_active Expired - Fee Related
- 2002-02-21 CN CNB028053230A patent/CN100408550C/zh not_active Expired - Fee Related
- 2002-02-21 SK SK5001-2011A patent/SK288149B6/sk not_active IP Right Cessation
- 2002-02-21 KR KR1020037010841A patent/KR100858972B1/ko not_active Expired - Fee Related
- 2002-02-21 CA CA2437702A patent/CA2437702C/en not_active Expired - Fee Related
- 2002-02-21 CZ CZ20032470A patent/CZ20032470A3/cs unknown
- 2002-02-21 HU HU0302755A patent/HUP0302755A3/hu unknown
- 2002-02-21 WO PCT/JP2002/001538 patent/WO2002066416A1/ja not_active Ceased
- 2002-02-21 NZ NZ52761502A patent/NZ527615A/xx not_active IP Right Cessation
- 2002-02-21 RO ROA200300695A patent/RO122639B9/ro unknown
- 2002-02-21 CA CA2683768A patent/CA2683768C/en not_active Expired - Fee Related
- 2002-02-21 RU RU2003128530/04A patent/RU2308447C2/ru not_active IP Right Cessation
- 2002-02-21 AU AU2002237527A patent/AU2002237527B2/en not_active Ceased
- 2002-02-21 IL IL15694902A patent/IL156949A0/xx unknown
- 2002-02-21 EE EEP200300373A patent/EE05361B1/et not_active IP Right Cessation
- 2002-02-21 KR KR1020077030609A patent/KR100864692B1/ko not_active Expired - Fee Related
- 2002-02-21 PL PL399009A patent/PL217238B1/pl unknown
- 2002-02-21 BR BRPI0207470-2A patent/BR0207470A/pt not_active IP Right Cessation
- 2002-02-21 MX MXPA03007528A patent/MXPA03007528A/es active IP Right Grant
2003
- 2003-07-15 IL IL156949A patent/IL156949A/en not_active IP Right Cessation
- 2003-07-25 BG BG108031A patent/BG108031A/bg unknown
- 2003-08-13 NO NO20033579A patent/NO328628B1/no not_active IP Right Cessation
- 2003-08-14 NZ NZ534374A patent/NZ534374A/xx not_active IP Right Cessation
2006
- 2006-09-08 US US11/517,621 patent/US7378555B2/en not_active Expired - Lifetime
2008
- 2008-03-28 JP JP2008085358A patent/JP4805967B2/ja not_active Expired - Lifetime
2009
- 2009-11-24 NO NO20093402A patent/NO331656B1/no not_active IP Right Cessation
2011
- 2011-08-11 AR ARP110102927A patent/AR082663A2/es not_active Application Discontinuation
2013
- 2013-04-23 BG BG10111453A patent/BG111453A/en unknown

Also Published As

Publication number	Publication date
EP1378505B1 (en)	2014-11-05
SK288073B6 (sk)	2013-05-03
AU2002237527B2 (en)	2007-01-04
CA2683768C (en)	2013-05-28
KR100858972B1 (ko)	2008-09-17
JP2008273952A (ja)	2008-11-13
NZ527615A (en)	2004-12-24
PL363440A1 (en)	2004-11-15
JP4210119B2 (ja)	2009-01-14
RU2308447C2 (ru)	2007-10-20
KR20080012383A (ko)	2008-02-11
MXPA03007528A (es)	2003-12-11
AR035684A1 (es)	2004-06-23
BG111453A (en)	2013-09-30
BG108031A (bg)	2005-04-30
RO125158A2 (ro)	2010-01-29
EP1378505A4 (en)	2006-09-27
US7378555B2 (en)	2008-05-27
HUP0302755A3 (en)	2008-03-28
US20070010674A1 (en)	2007-01-11
CN1492851A (zh)	2004-04-28
IL156949A (en)	2009-09-01
PL217238B1 (pl)	2014-06-30
TWI245768B (en)	2005-12-21
EP1378505A1 (en)	2004-01-07
PL218065B1 (pl)	2014-10-31
EE05361B1 (et)	2010-12-15
HUP0302755A2 (hu)	2003-12-29
BR0207470A (pt)	2008-04-08
US20040106830A1 (en)	2004-06-03
NO20093402L (no)	2003-10-10
RU2003128530A (ru)	2005-03-27
KR100864692B1 (ko)	2008-10-23
AR082663A2 (es)	2012-12-26
NO331656B1 (no)	2012-02-13
RO122639B9 (ro)	2014-03-28
IL156949A0 (en)	2004-02-08
CZ20032470A3 (cs)	2004-02-18
RO122639B1 (ro)	2009-10-30
US7126000B2 (en)	2006-10-24
JP4805967B2 (ja)	2011-11-02
NO20033579D0 (no)	2003-08-13
NZ534374A (en)	2004-12-24
CA2437702A1 (en)	2002-08-29
SK288149B6 (sk)	2013-12-02
KR20030077631A (ko)	2003-10-01
NO20033579L (no)	2003-10-10
NO328628B1 (no)	2010-04-12
CN100408550C (zh)	2008-08-06
SK11472003A3 (sk)	2004-03-02
CA2437702C (en)	2010-04-06
JPWO2002066416A1 (ja)	2004-09-24
PL399009A1 (pl)	2012-09-10
WO2002066416A1 (fr)	2002-08-29
CA2683768A1 (en)	2002-08-29

Publication	Publication Date	Title
EE200300373A (et)	2003-10-15	Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
CY2007029I2 (el)	2009-11-04	Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20035162D0 (no)	2003-11-20	Fremgangsmåte for fremstilling av prostaglandiner og analoger derav
NO20054715L (no)	2000-10-02	Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser
EE200300329A (et)	2003-10-15	Meetod peroraalselt manustatavate epotiloonide biosaadavuse suurendamiseks ning selles kasutatav komplekt, ravimkoostis ja farmatseutiline ravimvorm
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
IL158831A0 (en)	2004-05-12	METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
PL353633A1 (en)	2002-11-04	Method of obtaining derivatives of 4"-substituted-9-deoxy-9a-aza-9a-homoerythromycin
DE60216507D1 (de)	2007-01-11	Verfahren zur herstellung von polyetherimiden
EE05308B1 (et)	2010-06-15	Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
EE05247B1 (et)	2009-12-15	Meetod imidasoolhendite valmistamiseks
EE05403B1 (et)	2011-04-15	Tehniline snteesimeetod tropenooli valmistamiseks
DE60233589D1 (de)	2009-10-15	Verfahren zur herstellung von echinocandinderivaten
DE60033207D1 (de)	2007-03-15	Werkzeug zur herstellung von nockenwellen durch einwalzen
HUP0303055A3 (en)	2004-11-29	Polymorphs of zaleplon and methods for the preparation thereof and pharmaceutical compositions containing them
NO20035586D0 (no)	2003-12-15	Fremgangsmåte for fremstilling av cykloheksanol-derivater
DE60205521D1 (de)	2005-09-22	Verfahren zur Herstellung linearer Organohydrosiloxanen
ITMI20011132A1 (it)	2002-11-29	Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
EE200200410A (et)	2003-12-15	Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
DE60227896D1 (de)	2008-09-11	Verfahen zur Herstellung von Polyalkylphenoxyaminoalkanen
NO20033356D0 (no)	2003-07-25	Fremgangsmåte for fremstilling av DTPA-monoamider
ITMI20030018A1 (it)	2004-07-10	Procedimento per la preparazione di composti mono-
DE50203929D1 (de)	2005-09-22	Verfahren zur Herstellung von Polyfluoralkyllithium-Verbindungen
DE50209082D1 (de)	2007-02-08	Zwischenverbindungen zur herstellung von spinosynen
EE05131B1 (et)	2009-02-16	Meetod 20(S)-kamptotetsiini puhastamiseks

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2015-10-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20150221